プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Kirti K.に依頼

India

Scientific/Medical writer with experience in cancer biology and immunology

プロフィール概要

Presently, working as a freelancer Scientific and Medical Writer. I have 9 years of experience as a Ph.D. scholar at Bose Institute. My Ph.D. thesis work is related to anti-tumor therapy. My complete research work is dedicated to cancer biology and cancer immunology. I am well versed in basic lab techniques. Perseverance and dedication in this field developed my scientific thoughts. A rigorous study of research and review articles of peer-reviewed scientific journals developed scientific reading and writing skills. I have written my doctoral thesis, assisted my Principal Investigator in the editing-proof reading of manuscripts (submitted to various scientific journals), and in writing research proposals, reports, and grants for Institute. As a scientific writer, I have dealt with Psoriatic Arthritis, Osteoarthritis, Huntington`s Disease, drug repurposing, and summary of drugs in clinical trials. The scientific write-ups related to medical conditions included clinical manifestations, epidemiology, genetics, mechanism of action, comorbidities (& their prevalence), classification, diagnosis, biomarkers, and therapy. Certified with honors Writing in the Sciences an online non-credit course authorized by Stanford University and offered through Coursera.

専門分野

• ★ Breast Cancer
• ☆ Biochemistry
• ☆ Molecular Biology

サービス

• Writing

Writing Clinical Trial Documentation, Technical Writing

職務経験

PhD Researcher

Bose Institute

9月 2010 - 10月 2019

PhD Researcher

BOSE INSTITUTE

9月 2010 - 10月 2019

学歴

M.Sc.

Dr.B.R.Ambedkar Centre for Biomedical Research

7月 2008 - 4月 2010

B.Sc.

Birla Institute of Medical Research

4月 2005 - 4月 2008

認定資格

• How to become a great peer reviewer (Basic and Advanced Training)

  R UPSKILL

  10月 2020 - 現在

• Writing in the Sciences

  Stanford University

  9月 2020 - 現在

出版物

JOURNAL ARTICLE

Kirti Kajal and Sayantan Bose and Abir K. Panda and Dwaipayan Chakraborty and Sreeparna Chakraborty and Subhadip Pati and Tania Sarkar and Subhanki Dhar and Dia Roy and Shilpi Saha and Gaurisankar Sa(2021). Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients . Cancer Immunology, Immunotherapy. Springer Science and Business Media {LLC}

(2019). Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis. Scientific Reports.

(2018). Providence of the CD25(+) KIR(+) CD127(-) FOXP3(-) CD8(+) T-cell subset determines the dynamics of tumor immune surveillance. Immunology & Cell Biology.

(2017). Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells. Scientific Reports.

(2016). Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB-IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells. Cancer Research.

(2015). Intratumoral Immune Landscape: Immunogenicity to Tolerogenicity. Austin Journal of Clinical Immunology.

(2015). Sulphur alters NFκBp300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma. International Journal of Oncology.

(2014). Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin. Translational Research.

(2014). MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu. Immunology.

BOOK CHAPTER

(2017). Role of proteases in tumor immune evasion. In: Pathophysiological aspects of proteases. Pathophysiological Aspects of Proteases.